降糖药联合羟苯磺酸钙胶囊治疗糖尿病性白内障的临床疗效

2016-02-05李宏伟

中国卫生标准管理 2016年10期

李宏伟

李宏伟

【摘要】目的对降糖药联合羟苯磺酸钙胶囊治疗糖尿病性白内障的临床疗效进行分析。方法选取我院2013年7月～2014年7月收治的76例（138只眼）糖尿病性白内障患者，随机分为观察组和对照组，观察组患者接受降糖药联合羟苯磺酸钙胶囊的治疗，对照组患者仅接受降糖药的治疗，对比临床疗效。结果观察组空腹血糖、餐后2 h血糖及糖化血红蛋白水平均优于对照组（P＜0.05），观察组治疗总有效率（32.86%）高于对照组（7.35%）（P＜0.05）。结论降糖药联合羟苯磺酸钙胶囊治疗糖尿病性白内障疗效显著，可有效控制患者血糖水平。

【关键词】降糖药；羟苯磺酸钙胶囊；糖尿病性白内障；临床疗效

Objective To analyze the clinical effect of hypoglycemic agents combined with calcium dobesilate capsules in the treatment of diabetic cataract. Methods 76 cases（138 eyes）with diabetic cataract patients were selected in our hospital in July 2013 to July 2014，were randomly divided into the observation group and the control group，the patients in the observation group received the treatment of hypoglycemic drugs combined with hydroxyl benzene sulfonic acid calcium capsules，control group patients received only the treatment of hypoglycemic drugs. The clinical efficacy was compared. Results The fasting blood glucose，postprandial 2 h blood glucose and glycosylated hemoglobin levels were significantly better than the control（P ＜0.05），the total effective rate of the observation group（32.86%）was higher than that of the control group（7.35%）（P＜0.05）. Conclusion Hypoglycemic drugs combined with calcium dobesilate capsules in the treatment of diabetic cataract patients with significant effect，can effectively control the blood glucose level.

【Key words】 Diabetes，Hydroxy benzene sulfonic acid calcium capsules，Diabetic cataract，Clinical curative effect

流行病学资料认为［1-2］，随着糖尿病程的增加，患者并发糖尿病性白内障的几率逐渐升高，现阶段，手术是治疗白内障的有效方法之一，但糖尿病性白内障患者由于基础病的存在，术后可加速视网膜病变病程，严重可诱发黄斑病变，威胁患者的生命安全，因此对于糖尿病性白内障早期的预防控制是关键［3］。基于此，本研究以我院2013年7月～2014年7月收治的76例（138只眼）糖尿病性白内障患者为对象，分析探讨了降糖药联合羟苯磺酸钙胶囊治疗糖尿病性白内障的临床疗效。现报告如下。